<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Daffner, Scott D.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">BMP Uses, Risks, and Complications in Spine Surgery</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-01-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">30-31</style></pages><abstract><style  face="normal" font="default" size="100%">Bone morphogenetic proteins (BMPs) were used with increasing frequency in spine surgery after 2002, but their use has decreased as concerns have developed about possible cancer risk and complications. In this session, presenters discussed the evidence regarding BMPs and their associated cancer risk, other possible complications, and the patterns of BMP use since 2002.</style></abstract><number><style face="normal" font="default" size="100%">50</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>